Abionyx Pharma Sa Stock Net Income

ABNX Stock  EUR 1.24  0.02  1.64%   
Abionyx Pharma SA fundamentals help investors to digest information that contributes to Abionyx Pharma's financial success or failures. It also enables traders to predict the movement of Abionyx Stock. The fundamental analysis module provides a way to measure Abionyx Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Abionyx Pharma stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Abionyx Pharma SA Company Net Income Analysis

Abionyx Pharma's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

More About Net Income | All Equity Analysis

Current Abionyx Pharma Net Income

    
  (5.82 M)  
Most of Abionyx Pharma's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Abionyx Pharma SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Based on the recorded statements, Abionyx Pharma SA reported net income of (5.82 Million). This is 101.71% lower than that of the Healthcare sector and 108.31% lower than that of the Biotechnology industry. The net income for all France stocks is 101.02% higher than that of the company.

Abionyx Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Abionyx Pharma's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Abionyx Pharma could also be used in its relative valuation, which is a method of valuing Abionyx Pharma by comparing valuation metrics of similar companies.
Abionyx Pharma is currently under evaluation in net income category among its peers.

Abionyx Fundamentals

About Abionyx Pharma Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Abionyx Pharma SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Abionyx Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Abionyx Pharma SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Abionyx Stock

Abionyx Pharma financial ratios help investors to determine whether Abionyx Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Abionyx with respect to the benefits of owning Abionyx Pharma security.